PTGX R&D Expenses
Protagonist Therapeutics Inc · R&D Expenses
PTGX R&D Expenses
Latest reported$175.16Mperiod ending
PTGX R&D Expenses ($7.46M → $175.16M)
Annual R&D Expenses
High-resolution chart · PNG
PTGX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 159,290,000 | |
| 138,128,000 | |
| 120,161,000 | |
| 126,215,000 | |
| 126,006,000 | |
| 75,984,000 | |
| 65,003,000 | |
| 59,497,000 | |
| 46,181,000 | |
| 25,705,000 | |
| 11,831,000 | |
| 7,459,000 |